Both Bax and Bcl-2 have been confirmed to play critical roles in the leukemogenesis as well as multi-drug resistance of AML cells (Soderquist and Eastman, 2016; Pan et al., 2017; Reyna et al., 2017). Here, BCL2 is linked to acute myeloid leukemia.